1 1 2 Weight loss outcomes by engagement quartile *Based on a January 2026 analysis of 14,210 Noom GLP-1 Rx program members who joined between December 2024 and February 2025 and logged weight during a measurement week (4, 8, 16, 40 weeks) Total months persisted by engagement quartile *Based on a January 2026 analysis of 30,239 Noom GLP-1 Rx program members who joined between December 2024 and February 2025 Frequently Asked Questions Weight Loss and Engagement: January 2026 analysis of 14,203 Noom GLP-1 Rx Program members who started a GLP-1Rx plan between December 2024 and February 2025 and logged weight during a measurement week (4, 8, 16, 40 weeks)
These medications offer significant clinical benefits, including weight loss and improved blood sugar control
The most obvious indicator is exceeding the beyond-use date printed on the vial label by your compounding pharmacy
Market Expansion & Competition Rival GLP-1 pills are in late-stage development, including Eli Lillys orforglipron , which could be approved in 2026